期刊文献+
共找到381篇文章
< 1 2 20 >
每页显示 20 50 100
Bullous Pemphigoid Induced by Doxycycline: Case Report and Literature Review
1
作者 Mishal Al Mebayadh Rahaf Aldawish +1 位作者 Sohail A. Butt Abdulrahman Saad Aljahhan 《Case Reports in Clinical Medicine》 2024年第5期187-192,共6页
Bullous pemphigoid (BP) is the most prevalent autoimmune sub-epidermal blistering disease that affects mainly the elderly and could lead to serious morbidity. It has numerous risk factors and triggers, including an ag... Bullous pemphigoid (BP) is the most prevalent autoimmune sub-epidermal blistering disease that affects mainly the elderly and could lead to serious morbidity. It has numerous risk factors and triggers, including an aging population with several comorbidities and drug exposure. In the published paper, we reported a case about a 32 years old male patient with unknown medical conditions who presented with erythematous patches and plaques on the scalp, face, and trunk with scattered blisters two weeks after initiating doxycycline treatment for folliculitis. The exact pathogenesis of the drug-reaction in drug- associated bullous pemphigoid (DABP) remains controversial. In conclusion, it is crucial for clinicians to be aware of DABP when prescribing doxycycline. The purpose of this case report is to raise awareness of the possible association between bullous pemphigoid and doxycycline. 展开更多
关键词 bullous pemphigoid DOXYCYCLINE Drug-Associated bullous pemphigoid
下载PDF
Rituximab Therapy for Persistent, Severe and Extensive Idiopathic Bullous Pemphigoid
2
作者 Shaima Al-Bader Kamel El-Reshaid 《Journal of Cosmetics, Dermatological Sciences and Applications》 CAS 2023年第1期76-83,共8页
Background: Idiopathic Bullous Pemphigoid (IBP) is a rare blistering autoimmune disease. Its morbidity and mortality have remained high owing to complications of extensive skin involvement as well as its conventional ... Background: Idiopathic Bullous Pemphigoid (IBP) is a rare blistering autoimmune disease. Its morbidity and mortality have remained high owing to complications of extensive skin involvement as well as its conventional steroid therapy. We reviewed the medical literature and found indicators of an autoimmune etiology for its pathogenesis triggering genetically predisposed patients. Objective: to evaluate, prospectively, the role of Rituximab (R) therapy in its persistent, severe and extensive form. Patients and methods: A total of 12 patients, with disease duration of 6 ± 1 months, were treated with yearly R infusions (1 g followed by 1 g 2 weeks later). Results: Significant clinical improvement was achieved as documented by decrease in total score of Bullous Pemphigoid Disease Area Index from 60 ± 3 to 6 ± 2 that persisted for 26 ± 11 months of follow up. Moreover, IBP autoantibodies (anti-BP 180 and anti-320 IgG) levels fell from to 91 ± 3 and 81 ± 2 to 8 ± 2 and 9 ± 2, respectively. Conclusions: R is a safe and effective treatment for severe IBP and such response further confirms its autoimmune pathogenesis. 展开更多
关键词 bullous pemphigoid RITUXIMAB Treatment bp Autoantibodies bullous pemphigoid Disease Area Index
下载PDF
血清SOCS-1、SOCS-3及抗BP-180抗体水平与大疱性类天疱疮病情的相关分析
3
作者 李丙南 刘桂丽 +2 位作者 赵子申 张海祥 秦兰英 《中国中西医结合皮肤性病学杂志》 CAS 2024年第3期197-201,共5页
目的探讨血清细胞因子信号转导抑制蛋白-1(SOCS-1)、SOCS-3及抗大疱性类天疱疮(BP)-180抗体水平与BP病情的相关分析。方法选取2018年5月—2022年5月本院诊治的82例BP患者作为研究对象,并将其设立为观察组,同期选取41例健康体检者作为对... 目的探讨血清细胞因子信号转导抑制蛋白-1(SOCS-1)、SOCS-3及抗大疱性类天疱疮(BP)-180抗体水平与BP病情的相关分析。方法选取2018年5月—2022年5月本院诊治的82例BP患者作为研究对象,并将其设立为观察组,同期选取41例健康体检者作为对照组,并根据病情程度将82例BP患者分为轻度组(活动性皮损面积≤10%,n=28)、中度组(活动性皮损面积10%~30%,n=27)和重度组(活动性皮损面积>30%,n=27),展开回顾性研究,对比血清SOCS-1、SOCS-3、抗BP-180抗体水平及自身免疫性大疱性皮肤病严重程度评分(ABSIS);采用Pearson法分析SOCS-1、SOCS-3、抗BP-180抗体与ABSIS评分的相关性;并绘制受试者工作特征(ROC)曲线评估SOCS-1、SOCS-3、抗BP-180抗体诊断BP的曲线下面积(AUC)、敏感度和特异度。结果观察组的男性、女性均可发病,性别分布上差异无统计学意义,其中40~69岁为高发的年龄段。观察组的SOCS-1、SOCS-3、抗BP-180抗体及ABSIS均高于对照组(P<0.05)。重度组的SOCS-1、SOCS-3、抗BP-180抗体及ABSIS均高于轻度组和中度组(P<0.05);中度组的SOCS-1、SOCS-3、抗BP-180抗体及ABSIS均高于轻度组(P<0.05)。Pearson相关性分析显示,SOCS-1、SOCS-3、抗BP-180抗体与ABSIS呈正相关(r分别为0.441、0.580、0.723,P<0.001)。ROC曲线分析显示,SOCS-1、SOCS-3和抗BP-180抗体诊断BP的AUC值分别为0.696、0.765和0.965(P<0.05);敏感度分别为53.70%、41.50%和95.10%,特异度分别为87.80%、100.00%和85.40%。结论血清SOCS-1、SOCS-3及抗BP-180抗体水平与BP病情严重程度呈正相关,即其水平会随着病情程度变化而发生改变,临床可通过监测SOCS-1、SOCS-3及抗BP-180抗体水平变化为诊断BP及评估病情严重程度提供参考。 展开更多
关键词 细胞因子信号转导抑制蛋白-1 细胞因子信号转导抑制蛋白-3 bp-180抗体 大疱性类天疱疮
下载PDF
Topical use of ozone effectively alleviates the acute symptoms and quality of life of patients with moderate to severe bullous pemphigoid: a randomized controlled trial
4
作者 Li Li Li-Yun Sang +4 位作者 Wen-Guang Zhang Tong Wang Shu-Ping Guo Hong-Zhou Cui Hong-Ye Liu 《Frontiers of Nursing》 2021年第3期233-240,共8页
Objective:To evaluate the adjuvant treatment of acute stage symptoms and quality of life of patients with bullous pemphigoid(BP)with ozone.Methods:We included 74 patients with moderate and severe BP hospitalized from ... Objective:To evaluate the adjuvant treatment of acute stage symptoms and quality of life of patients with bullous pemphigoid(BP)with ozone.Methods:We included 74 patients with moderate and severe BP hospitalized from July 2018 to December 2020.The participants were randomly divided into the control group and the ozone group,with 37 patients in each group(n=37).The control group used tap water to wash the whole body,and mupirocin ointment was used for the erosions.The ozone group used ozone water to wash the whole body,and the erosion place was coated with ozone oil.The bullous pemphigoid disease area index(BPDAI)score of BP disease was used to observe the clinical symptoms and skin lesions of the two groups before and on day 3,7,and 14 after treatment.Pruritus and sleep were observed before and on day 3,7,and 14 after treatment.The Dermatology Life Quality Index(DLQI)was used to observe the quality of life before and after treatment and the adverse reactions were recorded.Results:The total BPDAI score and erythema score in the ozone group were significantly different from those in the control group on day 3,7,and 14 after treatment(P<0.050).The scab drying time and erosion drying time of ozone group were shorter than that of control group(P<0.001).There were statistically significant differences between the ozone group and the control group in pruritus score and sleep score on day 3,7,and 14 after treatment(P<0.001).There was statistically significant difference in skin disease quality of life between the two groups 14 days after treatment(P<0.001).No significant adverse reactions and complications were observed in both groups.Conclusions:Ozone external use can rapidly improve the acute stage of edema erythema,erosion,and itching of BP,improve the quality of life of patients,is an effective treatment method,and wor thy of clinical promotion. 展开更多
关键词 bullous pemphigoid erosion ERYTHEMA external use ITCH moderate-severe OZONE quality of life
下载PDF
Urticarial Bullous Pemphigoid: A New Case Report
5
作者 Waqas S. Abdulwahhab Fatima M. Al Qaydi 《Journal of Cosmetics, Dermatological Sciences and Applications》 CAS 2022年第3期145-152,共8页
Background: Bullous pemphigoid (BP) is the most common autoimmune bullous disease and it primarily affects the elderly population. It typically presents with tense bullae and severe pruritus. Non-bullous pemphigoid is... Background: Bullous pemphigoid (BP) is the most common autoimmune bullous disease and it primarily affects the elderly population. It typically presents with tense bullae and severe pruritus. Non-bullous pemphigoid is a subtype of BP characterized by lacking the typical bullae formation with different presentations including erythematous, eczematous, urticarial, polycyclic, targetoid, nodular, lichenoid, vesicular and erythrodermic. Aim: to document a new case presentation of urticarial BP who was treated for several years as chronic urticarial and chronic eczema. Case Report: A 56-year-old male patient presented with a history of recurrent severely pruritic urticarial wheals for 4 years duration involving the lower abdomen, lower back, upper and lower extremities associated with excoriations, keratosis, and post-inflammatory hyperpigmentations on resolved sites, diagnosed as urticarial BP on histopathology & direct immunofluorescence study (DIF) and was improved on systemic doxycycline therapy. Conclusion: BP can be presented with atypical manifestation. Urticarial BP is a rare variant of non-bullous pemphigoid that should be taken into consideration in the differential diagnosis of an atypical urticarial wheal not responding to conventional therapy. 展开更多
关键词 bullous pemphigoid Non-bullous pemphigoid Urticarial bullous pemphigoid Direct Immunofluorescence DOXYCYCLINE
下载PDF
Expression of MMP-2 and MMP-13 in Bullous Pemphigoid
6
作者 Haixiang Zhang Xiaoxu Shi +4 位作者 Lanying Qin Zishen Zhao Guojun Fu Jun Peng Wenjing Ye 《Journal of Clinical and Nursing Research》 2020年第1期7-10,共4页
Objective:To investigate the expression and significance of matrix metalloproteinase-2(MMP-2)and matrix metalloproteinase-13(MMP-13)in bullous pemphigoid(BP)skin lesions.Methods:Immunohistochemical SP method was used ... Objective:To investigate the expression and significance of matrix metalloproteinase-2(MMP-2)and matrix metalloproteinase-13(MMP-13)in bullous pemphigoid(BP)skin lesions.Methods:Immunohistochemical SP method was used to detect the expression of MMP-2 and MMP-13 in 32 BP skin lesions,and compared with 15 normal skin tissues.Results:The expression of MMP-2 in the case group was significantly increased(38.56±10.06)compared to the normal control group(21.20±5.98);the expression of MMP-13 in the case group was significantly augmented(18.62±5.90)compared to the normal control group(11.47±8.484).The expressions of MMP-2 and MMP-13 in the skin lesions of patients with bullous pemphigoid were statistically different from those of normal people(both P<0.05).Compared with the expression of MMP-2 and MMP-13 in bullous pemphigoid,the expression of MMP-2 and MMP-13 was moderately correlated(correlation coefficient was 0.523).Conclusion:The expression of MMP-2 and MMP-13 is significantly increased in bullous pemphigoid skin lesions,suggesting that they may play an important role in the pathogenesis of BP.There is a certain correlation between the expression of MMP-2 and MMP-13,suggesting that the high expression of MMP-13 may play a role in the mechanism that further leads to the high expression of MMP-2. 展开更多
关键词 MATRIX METALLOPROTEINASE MMP-2 MMP-13 bullous pemphigoid
下载PDF
Rare bullous pemphigoid during PD-1 inhibitor therapy:a case report
7
作者 Zuo-Peng Xiao Meng-Jun Nie Xi Zou 《Cancer Advances》 2022年第6期1-4,共4页
Immunotherapy is an important treatment modality in cancer,but it can also cause adverse reactions,with skin toxicity being the most common.The increasing number of immune checkpoint inhibitors being used in the clini... Immunotherapy is an important treatment modality in cancer,but it can also cause adverse reactions,with skin toxicity being the most common.The increasing number of immune checkpoint inhibitors being used in the clinic will inevitably cause an increase in the rate of adverse skin reactions that markedly affect the patient's quality of life.A 58-year-old patient with intrahepatic cholangiocareinoma developed bullous pemphigoid(BP)nearly a year after using immune checkpoint inhibitors,which is different from what has been reported inthe literature within two weeks of treatment.Pathologically,the skin biopsy diagnosis was epidermal hyperplasia and focal sub-epidermal pustule formation,consistent with drug-induced dermatitis.The patient was treated with methylprednisolone,minocyeline,colchicine,nicotinamide,triamcinolone,and traditional Chinese medicine decoction.No new blisters developed after 1 week of treatment.The medication was gradually discontinued,and BP did not recur.Clinicians should carefully consider the risk-benefit ratio when using PD-1 inhibitors,particularly concerning rash severity.Further studies are needed to investigate the relationship between adverse skin reactions and drug efficacy. 展开更多
关键词 case report immune checkpoint inhibitors bullous pemphigoid adverse skin reactions treatment
下载PDF
Preliminary Application of High-Frequency Ultrasound in the Differentiation of Pemphigus and Bullous Pemphigoid:An Observational Study
8
作者 Yang-Ai Liu Rong Cao +2 位作者 Mei-Hong Da Zheng-Bang Dong Fei Wang 《International Journal of Dermatology and Venereology》 CSCD 2024年第3期155-159,共5页
Objective:Ultrasonography is a diagnostic imaging technique used to visualize subcutaneous body structures for identification of possible pathologies.In this study,we aimed to explore the clinical significance of high... Objective:Ultrasonography is a diagnostic imaging technique used to visualize subcutaneous body structures for identification of possible pathologies.In this study,we aimed to explore the clinical significance of high-frequency ultrasound in differentiating the location of blisters between pemphigus and bullous pemphigoid.Methods:Eighteen patients were recruited in Department of Dermatology,Zhongda Hospital from 2020 to 2021 and divided into a pemphigus group(n=8)and a bullous pemphigoid group(n=10)according to the diagnostic criteria for each.Ultrasonographic images were collected using a 50-MHz high-frequency ultrasound system.The indexes of ultrasonic evaluation were the layer(epidermis or dermis),size,shape,internal echo,and boundary of the blister.Categorical variables are expressed as n(%),and differences were compared using Fisher’s exact test.Results:The ultrasonographic images in the pemphigus group showed an intraepidermal semi-arc or irregular anechoic or hypoechoic areas.The inferior borders were situated above the characteristic thin linear hyperechoic bands of the epidermis.A linear hypoechoic band was present at the dermoepidermal junction in some cases.In the ultrasonographic images of the bullous pemphigoid group,the linear hyperechoic bands of the epidermis were continuous and intact.An oval fluid anechoic area(subepidermal blister)was present immediately below the bands.The location of the blisters in the ultrasonographic images was significantly different between the 2 groups(P<0.001).Conclusion:High-frequency ultrasound can be used as an auxiliary means to differentiate the location of blisters between pemphigus and bullous pemphigoid. 展开更多
关键词 high-frequency ultrasound PEMPHIGUS bullous pemphigoid
原文传递
Esophagitis dissecans superficialis and autoimmune bullous dermatoses: A review 被引量:1
9
作者 Akira Hokama Yu-ichi Yamamoto +8 位作者 Kiyohito Taira Mitsuteru Nakamura Chiharu Kobashigawa Manabu Nakamoto Tetsuo Hirata Nagisa Kinjo Fukunori Kinjo Kenzo Takahashi Jiro Fujita 《World Journal of Gastrointestinal Endoscopy》 CAS 2010年第7期252-256,共5页
Esophagitis dissecans superficialis(EDS)is a rare and severe endoscopic finding characterized by sloughing of large fragments of esophageal mucosal lining.Although EDS has been reported in association with serious ill... Esophagitis dissecans superficialis(EDS)is a rare and severe endoscopic finding characterized by sloughing of large fragments of esophageal mucosal lining.Although EDS has been reported in association with serious illnesses and certain medications,the pathophysiological association of autoimmune bullous dermatoses with EDS has gained remarkable attention.Among these dermatoses,pemphigus vulgaris and pemphigoid frequently present with various types of esophageal involvement including EDS.We review the pathophysiology and clinical features of this involvement with the presentation of our experiences.The importance of endoscopic evaluation of this entity is discussed. 展开更多
关键词 ESOPHAGITIS dissecans superficialis Endoscopy AUTOIMMUNE bullous DERMATOSES Pemphigus vulgaris Mucous membrane pemphigoid bullous pemphigoid DESMOGLEIN
下载PDF
Oral Manifestations, Gingival Index and Dental State of Vesiculobullous Diseases
10
作者 Sergio Eduardo Migliorini Vanessa Gallego Arias Pecorari +3 位作者 Marcio Zaffalon Casati Claudia Giuli Santi Cyro Festa Neto Luciano Lauria Dib 《International Journal of Clinical Medicine》 2018年第5期408-422,共15页
Objective: To determine the occurrence of oral manifestations, gingival index, dental state and associated therapeutic aspects in patients with vesiculobullous diseases. Study design: Prospective and observational stu... Objective: To determine the occurrence of oral manifestations, gingival index, dental state and associated therapeutic aspects in patients with vesiculobullous diseases. Study design: Prospective and observational study conducted with 69 patients from May 2013 to May 2014 at the Dermatology Outpatient Clinic of the Clinical Hospital, University of S&atilde;o Paulo Medical School, Brazil. Data were analyzed for frequency in absolute values, percentage and correlation using the Chi-square test. Results: 84.1% of the patients had oral manifestations of vesiculobullous diseases (p = 0.001);25% had gingival lesions;18.2% had lesions in the buccal mucosa, and 17.6% in the lips, with no correlation between the location and the type of disease (p = 0.990). Among all patients with bullous pemphigoid, linear IgA dermatosis, and mucous membrane pemphigoid, 59 (93.6%) patients had gingival inflammation of dental origin but without significant correlation (p = 0.42). There was correlation between pemphigus vulgaris and periodontal disease (p = 0.05). Conclusion: Gingival inflammation seems to interfere negatively with the clinical course of these diseases. Further studies should be conducted to better clarify the interrelations between dental and gingival state, and between vesiculobullous diseases and oral involvement. 展开更多
关键词 Oral Medicine AUTOIMMUNE DISEASES PEMPHIGUS PERIODONTAL DISEASES bullous pemphigoid
下载PDF
IIF-SSS及BP180、BP230抗体检测在大疱性类天疱疮病情评估中的应用价值分析 被引量:1
11
作者 王娟 张晨阳 +2 位作者 朱伟红 于伟 倪文琼 《中国烧伤创疡杂志》 2023年第2期158-163,共6页
目的分析盐裂皮肤间接免疫荧光(IIF-SSS)及大疱性类天疱疮(BP)180、BP230抗体检测在BP病情评估中的应用价值。方法选取2018年7月至2020年7月郑州大学附属郑州中心医院收治的150例BP患者作为研究对象,收集患者就诊时及就诊后第30、60、18... 目的分析盐裂皮肤间接免疫荧光(IIF-SSS)及大疱性类天疱疮(BP)180、BP230抗体检测在BP病情评估中的应用价值。方法选取2018年7月至2020年7月郑州大学附属郑州中心医院收治的150例BP患者作为研究对象,收集患者就诊时及就诊后第30、60、180天的IIF-SSS滴度、BP180与BP230抗体水平、自身免疫性大疱性皮肤病严重程度评分(ABSIS)等资料,并根据皮损消退后6个月内是否复发将其分为复发组与非复发组,分析IIF-SSS滴度以及BP180、BP230抗体水平与ABSIS的相关性及对BP复发的预测价值。结果150例BP患者皮损消退后6个月内复发58例(38.67%),设为复发组;未复发92例(61.33%).设为未复发组。就诊后第30、60、180天,复发组患者IIF-SSS滴度、BP180与BP230抗体水平以及ABSIS均明显高于未复发组(就诊后第30天:t=4.256、2.828、2.894、2.612,P<0.001、P=0.005、P=0.004、P=0.010:就诊后第60天:t=3.959、10.080、5.312、3.182,P<0.001、P<0.001、P<0.001、P=0.002;就诊后第180天:t=2.928、12.240、17.020、8.575,P=0.004、P<0.001、P<0.001、P<0.001);Pearson相关性分析结果显示,IIF-SSS滴度以及BP180、BP230抗体水平与ABSIS均呈显著正相关性(r=0.215、0.243、0.196,P=0.008、0.003、0.016);受试者工作特征(ROC)曲线分析结果显示,IIF-SSS联合BP180、BP230抗体检测预测BP复发的曲线下面积(AUC)为0.826,敏感度为81.7%,特异度为78.8%结论IIF-SSS与BP180、BP230抗体检测能够有效评估BP患者病情严重程度,对BP复发具有较高的预测价值。 展开更多
关键词 大疱性类天疱疮 盐裂皮肤间接免疫荧光 bp180 bp230 酶联免疫吸附法 急性发作 预测价值
下载PDF
寻常性银屑病合并自身免疫性大疱性皮肤病13例临床分析
12
作者 周健 刘宇 +1 位作者 俞晨 王刚 《临床皮肤科杂志》 CAS CSCD 北大核心 2024年第7期387-392,共6页
目的:分析寻常性银屑病合并自身免疫性大疱性皮肤病患者的临床特点、诊断及治疗。方法:回顾性分析2008—2021年西京医院皮肤科确诊寻常性银屑病合并自身免疫性大疱性皮肤病住院患者的临床资料。结果:收集13例寻常性银屑病合并自身免疫... 目的:分析寻常性银屑病合并自身免疫性大疱性皮肤病患者的临床特点、诊断及治疗。方法:回顾性分析2008—2021年西京医院皮肤科确诊寻常性银屑病合并自身免疫性大疱性皮肤病住院患者的临床资料。结果:收集13例寻常性银屑病合并自身免疫性大疱性皮肤病患者,其中男8例,女5例,平均年龄(44.69±8.02)岁。所有患者于银屑病发生后平均(14.85±7.54)年合并自身免疫性大疱性皮肤病。所有患者中7例合并天疱疮(其中1例伴有汞中毒),5例合并大疱性类天疱疮(1例确诊肺腺癌),1例合并成人型线状Ig A大疱性皮病。7例患者采用糖皮质激素和(或)免疫抑制剂治疗,6例予单用免疫抑制剂治疗。出院后随访2个月~13年,10例患者治愈或病情稳定,3例失访。结论:寻常性银屑病可合并多种自身免疫性大疱性皮肤病,临床较为少见。患者多为银屑病病程中出现水疱、大疱性皮损,明确诊断需结合皮损组织病理表现、免疫荧光、疱病自身抗体等检查结果综合判断。提示临床上需警惕合并汞中毒可能,并重视对肿瘤的筛查和随访,根据疱病严重程度制定合理的治疗方案。 展开更多
关键词 银屑病 自身免疫性大疱性皮肤病 天疱疮 大疱性类天疱疮
下载PDF
临床药师参与1例大疱性类天疱疮、肺曲霉病合并播散性皮疽诺卡菌感染治疗的药学实践
13
作者 邓体瑛 林敏 +4 位作者 胡志敏 邹亮 吴志红 刘剑敏 黄蕾 《中国药房》 CAS 北大核心 2024年第16期2038-2043,共6页
目的为大疱性类天疱疮、肺曲霉病合并播散性皮疽诺卡菌感染患者的抗菌药物方案调整、不良反应识别和个体化药学监护提供参考。方法临床药师参与1例大疱性类天疱疮、肺曲霉病合并播散性皮疽诺卡菌感染患者的治疗全过程,结合循证证据协助... 目的为大疱性类天疱疮、肺曲霉病合并播散性皮疽诺卡菌感染患者的抗菌药物方案调整、不良反应识别和个体化药学监护提供参考。方法临床药师参与1例大疱性类天疱疮、肺曲霉病合并播散性皮疽诺卡菌感染患者的治疗全过程,结合循证证据协助临床遴选初期抗皮疽诺卡菌感染的联合治疗方案,并及时沟通微生物室以提供早期药敏数据;在患者出现癫痫时甄别可疑药物,并提醒临床亚胺培南西司他丁钠会影响丙戊酸钠疗效,建议将丙戊酸钠换为左乙拉西坦抗癫痫治疗,并停用亚胺培南西司他丁钠;治疗期间,建议临床对伏立康唑、利奈唑胺进行血药浓度监测,并根据监测结果协助临床及时调整用药剂量。结果医生采纳临床药师建议。患者病情好转,带药出院。结论临床药师基于循证医学证据、药敏试验结果和血药浓度监测数据,协助临床为患者选择敏感的抗感染方案;及时识别不良反应并调整治疗方案,并为患者提供全程用药监护,保证了临床药物治疗的安全性和有效性。 展开更多
关键词 皮疽诺卡菌感染 大疱性类天疱疮 肺曲霉病 癫痫 临床药师 药学监护
下载PDF
白细胞介素-17和白细胞介素-22在大疱性类天疱疮患者皮损及血清中的表达与意义
14
作者 崔瑜 吴远慧 +3 位作者 胡彩霞 王文氢 张燕 高顺强 《实用皮肤病学杂志》 2024年第1期25-29,47,共6页
目的检测分析大疱性类天疱疮(BP)患者皮损及血清中白细胞介素(IL)-17和IL-22的表达情况,并探讨其在BP发病机制中的意义。方法选取41例BP患者皮损组织(BP组)及25名健康人正常皮肤组织(对照组),用免疫组化方法检测IL-17和IL-22的表达情况... 目的检测分析大疱性类天疱疮(BP)患者皮损及血清中白细胞介素(IL)-17和IL-22的表达情况,并探讨其在BP发病机制中的意义。方法选取41例BP患者皮损组织(BP组)及25名健康人正常皮肤组织(对照组),用免疫组化方法检测IL-17和IL-22的表达情况。采用酶联免疫吸附试验(ELISA)检测27例BP患者血清中IL-17和IL-22的水平,并以25名健康人作为对照。结果BP组患者皮损中IL-17和IL-22的表达均明显高于对照组,差异有统计学意义(均P<0.01)。且BP组患者皮损组织中IL-17与IL-22的表达呈正相关性。BP组患者血清中IL-17和IL-22的表达水平均高于对照组,差异有统计学意义(均P<0.01)。BP组患者血清中IL-17与IL-22的表达呈正相关性。结论BP患者血清及皮损IL-17和IL-22的表达水平上调,可能参与BP的发病,且两者可能起协同作用。提示3型固有淋巴细胞(ILC3)可能参与BP的致病过程。 展开更多
关键词 类天疱疮 大疱性 白细胞介素-17 白细胞介素-22 固有淋巴细胞
下载PDF
抗桥粒芯蛋白1、3抗体及大疱性类天疱疮180、230抗体联合检测诊断大疱性皮肤病的应用价值
15
作者 徐珍珍 郑艳 刘俊杰 《分子诊断与治疗杂志》 2024年第3期416-420,共5页
目的 探讨抗桥粒芯蛋白1、3(Dsg1、3)抗体及大疱性类天疱疮180、230(BP180、230)抗体联合检测在大疱性皮肤病临床诊断中的应用价值。方法 自2020年3月至2023年1月,纳入郑州大学第一附属医院收治的经组织病理结果、直接免疫荧光检测确诊... 目的 探讨抗桥粒芯蛋白1、3(Dsg1、3)抗体及大疱性类天疱疮180、230(BP180、230)抗体联合检测在大疱性皮肤病临床诊断中的应用价值。方法 自2020年3月至2023年1月,纳入郑州大学第一附属医院收治的经组织病理结果、直接免疫荧光检测确诊的大疱性皮肤病患者88例为观察组,选取本院同期健康体检者76名为对照组。分析两组Dsg1、Dsg3、BP180、BP230抗体的阳性检出情况;分析观察组血清Dsg1、Dsg3、BP180、BP230抗体标本诊断类型占比及观察组不同年龄组大疱性皮肤病疾病类型阳性率占比;绘制ROC曲线分析Dsg1、Dsg3、BP180、BP230抗体单一及联合检测对大疱性皮肤病的诊断价值。结果 两组血清Dsg1、Dsg3、BP180、BP230抗体阳性率比较差异具有统计学意义(P<0.05)。据Dsg1、Dsg3、BP180、BP230抗体检测结果,诊断类型:BP、PV、PF、PF+BP、PV+BP阳性率分别为32.95%、20.45%、11.36%、7.95%、3.41%。其中BP阳性率占比最高,PV+BP阳性率占比最低,两者比较差异具有统计学意义(P<0.05)。>60岁组BP阳性率高于≤60岁组,PV及PF阳性率低于≤60岁组,差异有统计学意义(P<0.05)。Dsg1、Dsg3、BP180、BP230抗体联合检测对大疱性皮肤病灵敏度、特异度分别为91.02%、88.66%,AUC(95%CI)为0.821(0.745~0.911),均高于上述抗体单一检测(P<0.05)。结论 Dsg1、Dsg3、BP180、BP230抗体在大疱性皮肤病诊断中具有重要参考价值,且联合检测可提高诊断的准确性;大疱性皮肤病患者年龄和抗体类型之间也存在一定的关联,联合检测Dsg1、Dsg3、BP180、BP230抗体有助于大疱性皮肤病进行更精细的诊断和治疗。 展开更多
关键词 桥粒芯蛋白1 桥粒芯蛋白3 大疱性类天疱疮180 大疱性类天疱疮230 抗体 大疱性皮肤病
下载PDF
度普利尤单抗治疗老年难治性大疱性类天疱疮5例
16
作者 乌日嘎 贺伟 《皮肤科学通报》 2024年第4期430-435,共6页
度普利尤单抗治疗5例老年难治性大疱性类天疱疮(BP)患者。5例患者平均年龄为78.2岁,合并多种基础疾病。明确诊断后,给予其度普利尤单抗规律治疗3~5次,BP患者皮损得到控制,瘙痒明显缓解,定期随访中。度普利尤单抗是一种全人类IgG4单克隆... 度普利尤单抗治疗5例老年难治性大疱性类天疱疮(BP)患者。5例患者平均年龄为78.2岁,合并多种基础疾病。明确诊断后,给予其度普利尤单抗规律治疗3~5次,BP患者皮损得到控制,瘙痒明显缓解,定期随访中。度普利尤单抗是一种全人类IgG4单克隆抗体,通过与IL-4R和IL-13R-亚基的共同链结合,阻断IL-4/13信号传导途径,从而打断了BP发病的炎症通路,其还可通过对IL-4和IL-13的直接作用和对嗜酸性粒细胞的作用导致IL-31分泌减少,从而减少外周瘙痒感觉神经元的信号传递,因此可缓解老年BP的瘙痒问题。 展开更多
关键词 老年 难治性大疱性类天疱疮 度普利尤单抗
下载PDF
度普利尤单抗治疗大疱性类天疱疮16周疗效和安全性分析 被引量:2
17
作者 周昱希 李佶姝 +4 位作者 王金秋 李晓红 冯尘尘 周兴丽 李薇 《中国麻风皮肤病杂志》 2024年第1期21-25,共5页
目的:评价度普利尤单抗治疗大疱性类天疱疮(BP)的疗效与安全性。方法:回顾性分析2021年2月至2023年2月四川大学华西医院皮肤科应用度普利尤单抗治疗的BP患者临床、实验室资料及新冠感染情况,选择大疱性类天疱疮疾病面积指数评分(BPDAI)... 目的:评价度普利尤单抗治疗大疱性类天疱疮(BP)的疗效与安全性。方法:回顾性分析2021年2月至2023年2月四川大学华西医院皮肤科应用度普利尤单抗治疗的BP患者临床、实验室资料及新冠感染情况,选择大疱性类天疱疮疾病面积指数评分(BPDAI)和瘙痒数字评分量表(NRS)评价BP患者的皮损严重程度和瘙痒情况,Karnofsky评分评价患者功能状态,常见不良事件评价标准(CTCAE)5.0版评估发生的不良反应。结果:共纳入16例患者,随访16周后,8例(50%)达到疾病控制,6例(37.5%)达到疾病完全缓解,2例(12.5%)因疗效不佳或严重不良反应停用。BPDAI评分(8.37±9.45)和NRS评分(3.2±1.05)较治疗前(38.38±21.90;8.8±0.65)均明显下降,Karnofsky评分由基线(44.67±23.01)升高至(79.33±19.82),差异均有统计学意义(均P<0.05)。16例患者中3例(18.7%)感染新冠,对症或局部治疗后好转;其余病情稳定。1例(6.25%)出现呼吸衰竭、粒细胞下降,1例(6.25%)出现全身大汗,2例(12.5%)出现局部不良反应,未报道其他不良事件。结论:新冠感染疫情对于本次纳入的BP患者疾病管理未造成明显影响,度普利尤单抗治疗BP疗效好且安全性较高。 展开更多
关键词 度普利尤单抗 大疱性类天疱疮 临床疗效 安全性
下载PDF
度普利尤单抗联合外用糖皮质激素治疗结节性类天疱疮2例临床观察 被引量:1
18
作者 王麒钧 乌心怡 +2 位作者 赵肖庆 朱海琴 潘萌 《临床皮肤科杂志》 CAS CSCD 北大核心 2024年第5期291-295,共5页
例1女,70岁。躯干四肢反复斑丘疹、结节伴瘙痒1个月,水疱1周。皮肤组织病理:表皮轻度角化过度,颗粒层略增厚,棘层肥厚。真皮浅层小血管扩张,周围少量淋巴细胞浸润。血清间接免疫荧光示基底膜带IgG、C3线状沉积,酶联免疫吸附实验检测血清... 例1女,70岁。躯干四肢反复斑丘疹、结节伴瘙痒1个月,水疱1周。皮肤组织病理:表皮轻度角化过度,颗粒层略增厚,棘层肥厚。真皮浅层小血管扩张,周围少量淋巴细胞浸润。血清间接免疫荧光示基底膜带IgG、C3线状沉积,酶联免疫吸附实验检测血清抗BP180抗体、抗BP230抗体均阳性。例2男,77岁。全身反复红斑、丘疹、结节伴瘙痒半年,加重伴水疱2周。皮肤组织病理:表皮下水疱伴真皮浅层嗜酸性粒细胞浸润。皮肤直接免疫荧光示基底膜带IgG、C3线状沉积,酶联免疫吸附实验检测血清抗BP180抗体、抗BP230抗体均阳性。两例患者均诊断为结节性类天疱疮,由于存在系统糖皮质激素禁忌症,2例患者均采用外用强效糖皮质激素联合度普利尤单抗治疗,病情控制良好,逐渐停用后未见复发。 展开更多
关键词 结节性类天疱疮 度普利尤单抗 大疱性类天疱疮 外用糖皮质激素
下载PDF
大疱性类天疱疮患者嗜酸粒细胞相关指标与疾病严重程度相关性分析 被引量:1
19
作者 王甜雪 李梦琳 +3 位作者 郭涛 于研 苏畅 张峻岭 《中国中西医结合皮肤性病学杂志》 CAS 2024年第2期128-132,共5页
目的分析大疱性类天疱疮(BP)患者外周血及皮损组织中嗜酸粒细胞比例,皮损组织中嗜酸粒细胞趋化因子CCL11表达水平与疾病严重程度之间的相关性。方法本研究纳入65例自2019年1月—2021年1月期间于天津市中医药研究院附属医院皮肤科住院的B... 目的分析大疱性类天疱疮(BP)患者外周血及皮损组织中嗜酸粒细胞比例,皮损组织中嗜酸粒细胞趋化因子CCL11表达水平与疾病严重程度之间的相关性。方法本研究纳入65例自2019年1月—2021年1月期间于天津市中医药研究院附属医院皮肤科住院的BP患者,以及24例同一时间段在本院皮肤外科治疗的有医学美容需求的健康人群作为对照组。通过斯皮尔曼相关系数(Spearman correlation coefficient)分析BP患者外周血和皮损组织嗜酸粒细胞、皮损组织嗜酸粒细胞趋化因子CCL11与BP疾病面积指数(BPDAI)评分之间的相关性。结果BP患者外周血和皮损组织嗜酸粒细胞、皮损组织嗜酸粒细胞趋化因子CCL11与BPDAI评分呈正相关(P<0.05);外周血和皮损组织嗜酸粒细胞、皮损组织嗜酸粒细胞趋化因子CCL11均与患者的红斑评分、水疱评分之间有相关性(P<0.05),与患者的损害评分、黏膜评分无相关性;BP患者外周血嗜酸粒细胞与患者的瘙痒评分有相关性(P<0.05)。结论BP患者外周血和皮损组织嗜酸粒细胞、皮损组织嗜酸粒细胞趋化因子CCL11与BPDAI评分之间存在相关性,可在一定程度上反应BP病情严重程度,且可推断其在BP的红斑、水疱形成机制中发挥了一定的作用,此外,外周血嗜酸粒细胞的升高可能与皮肤瘙痒形成机制有关。 展开更多
关键词 大疱性类天疱疮 嗜酸粒细胞 趋化因子 嗜酸粒细胞趋化因子CCL11
下载PDF
卡瑞丽珠长期治疗后发生大疱性类天疱疮一例
20
作者 郑淳之 张民阔 +5 位作者 赛雯雯 曹园园 张朝霞 潘付堂 杨宝琦 刘红 《中国麻风皮肤病杂志》 2024年第6期422-424,共3页
免疫检查点抑制剂(Immune Checkpoint inhibitors, ICI)为肿瘤的治疗带来了颠覆性的改革,但同时也导致较多免疫相关不良事件(immune-related adverse events, irAE)的发生。其中,大疱性类天疱疮(bullous pemphigoid, BP)是一种罕见的ir... 免疫检查点抑制剂(Immune Checkpoint inhibitors, ICI)为肿瘤的治疗带来了颠覆性的改革,但同时也导致较多免疫相关不良事件(immune-related adverse events, irAE)的发生。其中,大疱性类天疱疮(bullous pemphigoid, BP)是一种罕见的irAE,主要表现为红斑基础上出现水疱,疱壁紧张。本文报道1例发生于卡瑞丽珠长期治疗后的大疱性类天疱疮,并对ICI引起BP的诊断及治疗策略进行总结。 展开更多
关键词 PD-1抑制剂 卡瑞丽珠单抗 大疱性类天疱疮
下载PDF
上一页 1 2 20 下一页 到第
使用帮助 返回顶部